Site updated at Wednesday, 22 June 2016

Living with Dementia


Merck becomes bigger Alzheimer’s player, with new trial

Merck & Co Inc has moved to the forefront of Alzheimer’s disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease.

The drugmaker said on Monday it had started the trial to evaluate… Merck becomes bigger Alzheimer’s player, with new trial   

Parkinson’s Disease Dementia

razadyne1 - parkinson's risk2 - clinical conclusions1 - signs of alzheimers1 - gammagard1 - multiple system atrophy1 - amyloid-ß peptide1 - people with dementia4 - pseudogeneral paralysis1 - vascular dementia warning signs1 - amylin1 - alzheimer's disease195 - atherosclerosis7 - impaired-memory disorder1 - huntington's1 - alzheimer's prevention1 - imbeciles1 - amyloidosis1 - caregiving2 - normal aging1 - living with dementia1 - down syndrome2 - mediterranean diet1 - memory impairment2 - behavioral signs1 - glucose hypometabolism1 - alzheimer's brain1 - neuronal membrane1 - apoe2 - cognitive testing2 -